Journal profile · Medicine, Research & Experimental
Advances in Medical Sciences
ISSN 1896-1126 · eISSN 1898-4002 · Elsevier BV · POLAND · Annual · Founded 2006
Advances in Medical Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.48; hybrid open access; APC about USD 2,550; median 228 days to acceptance (94 articles, last 24 months); community-reported acceptance: easy; 52 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Advances in Medical Sciences is published by Elsevier BV and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Diverse Scientific and Economic Studies and Human auditory perception and evaluation, together about 17.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines.The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments.Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.The journal welcomes submissions from the following disciplines:General and internal medicine,Cancer research,Genetics,Endocrinology,Gastroenterology,Cardiology and Cardiovascular Medicine,Immunology and Allergy,Pathology and Forensic Medicine,Cell and molecular Biology,Haematology,Biochemistry,Clinical and Experimental Pathology.Only review articles from experts in the field will be considered for publication. The journal does not accept case reports.
From the journal's Aims & Scope
Research area (LetPub): Medicine, Research & Experimental
Editor-in-chief Jacek NiklińskiPublisher website
Editorial board by country: none in mainland China; most named Poland 37, Germany 13, United States 10, Italy 6, Sweden 2 (75 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine7.3%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.2%
- Human auditory perception and evaluationEngineering5.2%
- Educational Robotics and EngineeringComputer Science5.2%
- Helicobacter pylori-related gastroenterology studiesMedicine4.8%
- Pancreatitis Pathology and TreatmentMedicine4.8%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.6%
- Atrial Fibrillation Management and OutcomesMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.48LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- CiteScore 2026-06
- 4.8LetPub ·
- CiteScore (publisher)
- 4.8Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 31LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 531OpenAlex ·
- 2-year mean citedness
- 2.47OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 27.5%LetPub ·
Volume
- Articles per year
- 43LetPub ·
Articles by year OpenAlex count · 1,071 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 19 | 10 |
| 2025 | 52 | 21 | 68 |
| 2024 | 66 | 23 | 312 |
| 2023 | 56 | 13 | 438 |
| 2022 | 47 | 14 | 618 |
| 2021 | 57 | 21 | 852 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
228 daysMedian, submission to acceptance · P25–P75 172 days – 305 days
- Acceptance to online
- median 1 days (94 articles)
- Submission to online
- median 231 days
- Sample
- 94 articles with submission and acceptance dates (97 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 11 daysPublisher website ·
- First decision after review
- 62 daysPublisher website ·
- Submission to acceptance
- 217 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,550 / EUR 2,390 / GBP 2,040 / JPY 316,280 | — | — | |
| Publisher website | USD 2,550 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Vancouver
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted5
- editorialsThe journal accepts original research articles, editorials, letters to editor and review articles.Length not stated
- letters to editorThe journal accepts original research articles, editorials, letters to editor and review articles.Length not stated
- original research articlesThe journal accepts original research articles, editorials, letters to editor and review articles.Length not stated
- reviewManuscripts are evaluated on the basis that they present new insights to the investigated topic, are likely to contribute to a research progress. It is understo…Length not stated
- review articlesThe journal accepts original research articles, editorials, letters to editor and review articles.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Generative AI use must be declared Model summary
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Changes to authorship
Institutional email required for corresponding author Model summary
The editors of this journal generally will not consider changes to authorship once a manuscript has been submitted. It is important that authors carefully consider the authorship list and order of authors and provide a definitive author list at submission. The policy of this journal around authorship changes: All authors must be listed in the manuscript and their details entered into the submissio…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
Declaration of interests required in two places Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- Publication ethics
Human subjects research must comply with Declaration of Helsinki Model summary
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Review process
Double anonymized review process Model summary
Manuscripts are evaluated on the basis that they present new insights to the investigated topic, are likely to contribute to a research progress. It is understood that all authors listed on a manuscript have agreed to its submission. The signature of the corresponding author on the letter of submission signifies that these conditions have been fulfilled. Received manuscripts are first examined by …
Source ↗Publisher website ·- Preprints Preprint references
Preprints not accepted Model summary
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier BV
- Country or region
- POLAND
- Language
- English
- Frequency
- Annual
- Founded
- 2006
- ISSN
- 1896-1126
- Electronic ISSN
- 1898-4002
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Advances in Medical Sciences
What CAS zone is Advances in Medical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Advances in Medical Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Advances in Medical Sciences?
The latest impact factor listed by LetPub is 2.48; CiteScore 4.8, h-index 60.
How long does peer review take at Advances in Medical Sciences?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 228 days (interquartile range 172–305 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Advances in Medical Sciences?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Vancouver; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Advances in Medical Sciences based?
Of the 75 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (37), Germany (13) and United States (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Advances in Medical Sciences?
According to LetPub and DOAJ records, Advances in Medical Sciences is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Advances in Medical Sciences open access, and what is the APC?
Advances in Medical Sciences is a hybrid journal. For open-access publication: APC about USD 2,550.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .